Verweij J - Search Results

1

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients.

de Wit R, Kruit WH, Stoter G, de Boer M, Kerger J, Verweij J. de Wit R, et al. Among authors: verweij j. Br J Cancer. 1998 Nov;78(10):1342-5. doi: 10.1038/bjc.1998.681. Br J Cancer. 1998. PMID: 9823976 Free PMC article. Clinical Trial.

2

A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours.

Verweij J, Planting A, van der Burg M, Stoter G. Verweij J, et al. J Cancer Res Clin Oncol. 1992;118(8):606-8. doi: 10.1007/BF01211805. J Cancer Res Clin Oncol. 1992. PMID: 1325463 Free article. Clinical Trial.

3

Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.

de Wit R, Tesselaar M, Kok TC, Seynaeve C, Rodenburg CJ, Verweij J, Helle PA, Stoter G. de Wit R, et al. Among authors: verweij j. Eur J Cancer. 1991;27(11):1383-5. doi: 10.1016/0277-5379(91)90015-6. Eur J Cancer. 1991. PMID: 1835851 Clinical Trial.

4

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

Verweij J, Herweijer H, Oosterom R, van der Burg ME, Planting AS, Seynaeve C, Stoter G, Nooter K. Verweij J, et al. Br J Cancer. 1991 Aug;64(2):361-4. doi: 10.1038/bjc.1991.307. Br J Cancer. 1991. PMID: 1892765 Free PMC article. Clinical Trial.

5

5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.

van der Gaast A, Verweij J, Planting AS, Stoter G. van der Gaast A, et al. Among authors: verweij j. Eur J Cancer Clin Oncol. 1988 Apr;24(4):765-8. doi: 10.1016/0277-5379(88)90312-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383976

6

Phase II study on oral N-methylformamide in metastatic colorectal cancer.

Planting AS, Klijn JG, Verweij J, Stoter G. Planting AS, et al. Among authors: verweij j. Cancer Treat Rep. 1987 Dec;71(12):1293-4. Cancer Treat Rep. 1987. PMID: 3690540 No abstract available.

7

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.

Bontenbal M, Planting AS, Verweij J, de Wit R, Kruit WH, Stoter G, Klijn JG. Bontenbal M, et al. Among authors: verweij j. Breast Cancer Res Treat. 1995 May;34(2):185-9. doi: 10.1007/BF00665790. Breast Cancer Res Treat. 1995. PMID: 7647335 Free article. Clinical Trial.

8

Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.

de Wit R, van der Burg ME, van den Gaast A, Logmans A, Stoter G, Verweij J. de Wit R, et al. Among authors: verweij j. Ann Oncol. 1994 Sep;5(7):656-7. doi: 10.1093/oxfordjournals.annonc.a058942. Ann Oncol. 1994. PMID: 7993845 Free article. Clinical Trial.

9

Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.

Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: verweij j. Br J Cancer. 1993 Oct;68(4):789-92. doi: 10.1038/bjc.1993.429. Br J Cancer. 1993. PMID: 8398709 Free PMC article. Clinical Trial.

10

Oral piritrexim, an effective treatment for metastatic urothelial cancer.

de Wit R, Kaye SB, Roberts JT, Stoter G, Scott J, Verweij J. de Wit R, et al. Among authors: verweij j. Br J Cancer. 1993 Feb;67(2):388-90. doi: 10.1038/bjc.1993.71. Br J Cancer. 1993. PMID: 8431372 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

929 results

Search Page

Filters